International Spotlight on cecava’s Individualized Peptide Cancer Therapy (INPECT)
Our approach to individualized peptide therapy for IDH1-mutated gliomas is gaining international attention. Precision Medicine Online is an established news and analysis portal for precision oncology. It recently published an article based on an in-depth interview with our Managing Director, Saskia Biskup, MD/PhD. She spoke about the scientific basis of our approach, the results achieved so far, and the next steps toward a clinical trial.
The article summarizes the key points from the conversation and links them to current developments in precision oncology. It explains how the individualized peptide therapy works, outlines its potential for treating IDH1-mutated gliomas, and shows why this approach could become a valuable addition to existing treatments.
Read the full article on Precision Medicine Online here (subscription required).
